who makes tirzepatide FDA approves new weight loss drug with remarkable track record Eli Lilly gets nod to

Severe or blood glucose confirmed symptomatic hypoglycemia (glucose of 56 mg/dL or less) occurred in 6.5% and 10.4% of patients when semaglutide 0.5 mg and 1 mg, respectively, when coadministered with a sulfonylurea

Research shows GLP-1 medications like Ozempic (semaglutide) increase gastroparesis risk 3.67 times compared to alternative weight loss drugs, though most cases reverse after stopping the medication

RTL (in French)

Is there solid proof from large, rigorous scientific studies (the kind that informs EBM)

Should I stop taking omega 3 if I notice increased hair shedding

Brain-based biotypes of psychiatric vulnerability in the acute aftermath of trauma